Items where authors include "McLaren, D."

Article

McLaren, D. and Corry, O. orcid.org/0000-0002-7249-0913 (2025) Carbon Dioxide Removal: What Is Sustainable and Just? Environment: Science and Policy for Sustainable Development, 67 (1). pp. 59-69. ISSN 0013-9157

Engl, R., Cook, M., Bradley-Lovekin, T. et al. (10 more authors) (2025) Rich man, poor man: excavations at the Canongate poorhouse, New Waverley, Calton Road, Edinburgh. Scottish Archaeological Internet Reports, 108. pp. 1-72. ISSN 1473-3803

McLaren, D. and Corry, O. orcid.org/0000-0002-7249-0913 (2025) Solar geoengineering research faces geopolitical deadlock. Science, 387 (6729). pp. 28-30. ISSN 0036-8075

Corry, O. orcid.org/0000-0002-7249-0913, McLaren, D. and Kornbech, N. (2024) Scientific models versus power politics: How security expertise reframes solar geoengineering. Review of International Studies. ISSN 0260-2105

Kornbech, N., Corry, O. orcid.org/0000-0002-7249-0913 and McLaren, D. (2024) Securing the ‘great white shield’? Climate change, Arctic security and the geopolitics of solar geoengineering. Cooperation and Conflict. ISSN 0010-8367

Rescigno, P., Porta, N., Finneran, L. et al. (26 more authors) (2024) Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial. European Journal of Cancer, 205. 114103. ISSN 0959-8049

Renforth, P., Bellamy, R., Beerling, D. et al. (17 more authors) (2023) Specialty grand challenge: renaming our section to “Carbon Dioxide Removal”. Frontiers in Climate, 5. 1279109. ISSN 2624-9553

Corry, O. orcid.org/0000-0002-7249-0913 and McLaren, D. (2023) "Our way of life is not up for negotiation!": Climate interventions in the shadow of ‘societal security’. Global Studies Quarterly, 3 (3). ksad037. ISSN 2634-3797

Brown, J.E. orcid.org/0000-0003-4960-3032, Royle, K.-L., Gregory, W. et al. (96 more authors) (2023) Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. The Lancet Oncology, 24 (3). pp. 213-227. ISSN 1470-2045

James, N., Pirrie, S., Pope, A. et al. (17 more authors) (2016) TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration-refractory prostate cancer. Health Technology Assessment, 20. 53. ISSN 1366-5278

Andronis, L., Goranitis, I., Pirrie, S. et al. (19 more authors) (2016) Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747). BJU International. ISSN 1464-4096

Powles, T., Brown, J., Larkin, J. et al. (17 more authors) (2016) A randomized, double-blind phase II study evaluating cediranib versus cediranib and saracatinib in patients with relapsed metastatic clear-cell renal cancer (COSAK). Annals of Oncology, 27 (5). pp. 880-886. ISSN 0923-7534

James, N.D., Pirrie, S.J., Pope, A.M. et al. (19 more authors) (2016) Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both. JAMA Oncology, 2 (4). p. 493. ISSN 2374-2437

Monograph

McLaren, D. and Corry, O. orcid.org/0000-0002-7249-0913 (2024) Carbon Dioxide Removal - What is Sustainable and Just? Report. Quaker United Nations Office

Proceedings Paper

Huddart, R., Birtle, A., Cheung, K.C. et al. (19 more authors) (2023) Randomised phase II trial of adaptive image guided bladder radiotherapy: Disease control data. In: Radiotherapy & Oncology. ESTRO 2023, 13-16 May 2023, Vienna, Austria. Elsevier , S704-S705.

Huddart, R., Birtle, A., Cheung, K.C. et al. (19 more authors) (2023) Randomised phase II trial of adaptive image guided bladder radiotherapy: patient reported outcomes. In: Radiotherapy & Oncology. ESTRO 2023, 13-16 May 2023, Vienna, Austria. Elsevier , S331-S332.

Huddart, R.A., Hafeez, S., Omar, A. et al. (17 more authors) (2023) Randomised phase II trial of adaptive image guided radiotherapy in muscle invasive bladder cancer: Late toxicity and cancer outcomes. In: Journal of Clinical Oncology. 2023 ASCO Genitourinary Cancers Symposium, 16-18 Feb 2023. American Society of Clinical Oncology .